BIONOMICS LIMITED - AMERICAN DEPOSITORY SHARES

Bionomics Limited Announces Private Placement of up to $70.0 Million

31 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

20 май 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder

21 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the 2024 BIO CEO & Investor Conference

22 фев 2024 16:30:00 Источник Nasdaq GlobeNewswire

Bionomics Provides a Review of 2023 and of 2024 Plans

22 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at Biotech Showcase™ 2024

05 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting

06 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder

16 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

28 сен 2023 06:00:52 Источник Nasdaq GlobeNewswire

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

14 сен 2023 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210

23 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

31 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth

03 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at Upcoming June Investor Conferences

15 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire

Bionomics Announces Upcoming Poster Presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

30 май 2023 06:00:00 Источник Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

28 апр 2023 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

27 апр 2023 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)

08 мар 2023 19:00:30 Источник Nasdaq GlobeNewswire

Bionomics’ Half-Year Report

23 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire

Quarterly Activities and Cashflow Report

30 янв 2023 18:23:46 Источник Nasdaq GlobeNewswire